Cover Image
市場調查報告書

梅毒檢驗的全球市場:2015∼2019年

Global Syphilis Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345508
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
梅毒檢驗的全球市場:2015∼2019年 Global Syphilis Testing Market 2015-2019
出版日期: 2015年11月18日 內容資訊: 英文 70 Pages
簡介

梅毒是性感染疾病之一,2014年全球有3,600萬人感染梅毒。透過感染的早期診斷可能迅速回復。在梅毒檢測的檢驗中,有酵素免疫分析法檢驗,性病研究所檢驗,急速血漿反應素檢驗,就地檢驗套件。全球梅毒檢驗市場預計2014∼2019年以年複合成長率4.71%擴大。

本報告提供全球梅毒檢驗市場相關調查,該市場的現狀與至2019年的成長前景,各地區趨勢,主要供應商概要,市場課題與趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 梅毒檢驗的應用

第7章 各技術市場區隔

  • POC梅毒檢驗
  • 傳統的梅毒檢驗
  • 為了查出梅毒感染的篩檢法

第8章 各產品市場區隔

  • 化驗/消耗品
  • 設備

第9章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

  • 梅毒的罹患率、發病率的增加
  • POC梅毒檢驗引進的增加
  • 意識提升和政府的配合

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • 2014年的市場佔有率分析
  • 其他值得注意的供應商

第16章 主要供應商分析

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare

第17章 附錄

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR7876

About syphilis testing

Syphilis is a type of sexually transmitted infections disease caused by the bacteria Treponema pallidum subspecies pallidum. The infection spreads mainly through sexual contact. Congenital syphilis, however, affects infants by transmission of the infection from the infected mother to the fetus. The rate of syphilis infection is high among men and particularly in those men who have sex with men. In 2014, around 36 million people worldwide were infected by syphilis. The global burden of syphilis is gradually increasing. Unprotected sex and sexual intercourse with multiple partners, affected by syphilis infection are the key factors contributing to the spread of this infection. However, early diagnosis of the infection enables quick recovery from the disease. Testing methods employed for syphilis detection includes enzyme immunoassay (EIA) test, venereal disease research laboratory (VDRL) test, rapid plasma reagin (RPR) test, and point of care (POC) test kits.

Technavio's analysts forecast the global syphilis testing market to grow at a CAGR of 4.71% over the period 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global syphilis testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following product categories:

  • POC syphilis test
  • Conventional syphilis test (non-treponemal serology and treponemal serology test)

Technavio's report, Global Syphilis Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott Diagnostic
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare

Other Prominent Vendors

  • AccuBioTech
  • Becton Dickinson and Company
  • bioLytical Laboratories
  • Bio-Rad Laboratories
  • Chembio Diagnostic Systems
  • Diasorin
  • DRG International
  • Grifols
  • IBL International
  • MedMira
  • Omega Diagnostics
  • Trinity Biotech
  • ulti med Products
  • ZEUS Scientific

Key market driver

  • Increasing prevalence and incidence of syphilis
  • For a full, detailed list, view our report

Key market challenge

  • Discrepancies associated with the syphilis test results
  • For a full, detailed list, view our report

Key market trend

  • Advances in technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Syphilis test application

PART 07: Market segmentation by technology

  • POC syphilis test
  • Conventional syphilis test
  • Screening approaches to detect syphilis infection

PART 08: Market segmentation by product

  • Assays/consumables
  • Instruments

PART 09: Geographical segmentation

  • Syphilis testing market in Americas
  • Syphilis testing market in EMEA
  • Syphilis testing market in APAC

PART 10: Market drivers

  • Increase in prevalence and incidence of syphilis
  • Increase in adoption of POC syphilis test
  • Increase in awareness and government initiatives

PART 11: Impact of drivers

PART 12: Market challenges

  • Discrepancies associated with syphilis test results
  • High-cost products
  • Social stigma associated with syphilis screening

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Advances in technology
  • Focus on rapid and early diagnosis
  • High growth in emerging countries

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare

PART 17: Appendix

  • List of abbreviation

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global syphilis testing market 2014-2019 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Syphilis testing applications
  • Exhibit 05: Application and limitations of diagnostic tests in various stages of syphilis
  • Exhibit 06: Segmentation of global syphilis testing market by technology
  • Exhibit 07: Segmentation of global syphilis testing market by technology 2014
  • Exhibit 08: Traditional algorithm method of syphilis screening
  • Exhibit 09: Reverse algorithm method of syphilis screening
  • Exhibit 10: Segmentation of global syphilis testing market by product
  • Exhibit 11: Segmentation of global syphilis testing market by product 2014
  • Exhibit 12: Segmentation of global syphilis testing market by geography 2014
  • Exhibit 13: Segmentation of global syphilis testing market by geography 2019
  • Exhibit 14: Segmentation of global syphilis testing market by geography 2014-2019
  • Exhibit 15: Syphilis testing market in Americas 2014-2019 ($ millions)
  • Exhibit 16: Syphilis testing market in EMEA 2014-2019 ($ millions)
  • Exhibit 17: Distribution of syphilis cases by stage of infection in Europe 2014
  • Exhibit 18: Percentage of syphilis cases by transmission in Europe 2014
  • Exhibit 19: Syphilis testing market in APAC 2014-2019 ($ billions)
  • Exhibit 20: Impact of drivers
  • Exhibit 21: Impact of drivers and challenges
  • Exhibit 22: Key takeaways: Abbott Diagnostics
  • Exhibit 23: Key takeaways: Alere
  • Exhibit 24: Key takeaways: Beckman Coulter
  • Exhibit 25: Key takeaways: Roche Diagnostics
  • Exhibit 26: Key takeaways: Siemens Healthcare
  • Exhibit 27: Abbott Diagnostics: Key business offerings
  • Exhibit 28: Alere: Business segmentation by revenue 2014
  • Exhibit 29: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 30: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
  • Exhibit 31: Beckman Coulter: Business segmentation
  • Exhibit 32: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 33: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 34: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 35: Siemens Healthcare: Business segmentation
  • Exhibit 36: Siemens Healthcare: Geographical segmentation by revenue 2014
Back to Top